Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions

Eur J Neurosci. 2000 Jul;12(7):2215-23. doi: 10.1046/j.1460-9568.2000.00110.x.

Abstract

The peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a member of a large group of nuclear receptors controlling the proliferation of peroxisomes that is involved in the downregulation of macrophage functions. Here, we report that PPAR-gamma was constitutively expressed in rat primary microglial cultures and that such expression was downregulated during microglial activation by endotoxin (LPS). The presence of the PPAR-gamma natural ligand 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) counteracted the repression of PPAR-gamma expression caused by LPS. In microglial cultures stimulated by LPS, interferon-gamma (IFN-gamma) or by their combination, 15d-PGJ2 reduced the production of nitric oxide (NO) and the expression of inducible NO synthase (iNOS). The inhibitory effect was dose-dependent and did not involve an elevation of cyclic AMP, a second messenger known to inhibit NOS expression in microglia. In addition, 15d-PGJ2 down-regulated other microglial functions, such as tumour necrosis factor-alpha (TNF-alpha) synthesis and major histocompatibility complex class II (MHC class II) expression. The effects of 15d-PGJ2 occurred, at least in part, through the repression of two important transcription factors, the signal transducer and activator of transcription 1 and the nuclear factor kappaB, known to mediate IFN-gamma and LPS cell signalling. Our observations suggest that 15d-PGJ2, the synthesis of which is likely to occur within the brain, could play an important role in preventing brain damage associated with excessive microglial activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives
  • Adenine / pharmacology
  • Adenylyl Cyclase Inhibitors
  • Animals
  • Blotting, Western
  • Cells, Cultured
  • DNA-Binding Proteins / biosynthesis
  • Dinoprostone / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Interferon-gamma / biosynthesis
  • Lipopolysaccharides / pharmacology
  • Microglia / cytology
  • Microglia / drug effects
  • Microglia / enzymology*
  • NF-kappa B / biosynthesis
  • Nitric Oxide / biosynthesis
  • Nitric Oxide Synthase / analysis
  • Nitric Oxide Synthase / biosynthesis
  • Nitric Oxide Synthase Type II
  • Prostaglandin D2 / analogs & derivatives*
  • Prostaglandin D2 / pharmacology
  • Rats
  • Receptors, Cytoplasmic and Nuclear / analysis
  • Receptors, Cytoplasmic and Nuclear / metabolism*
  • STAT1 Transcription Factor
  • Signal Transduction / drug effects
  • Signal Transduction / immunology
  • Trans-Activators / biosynthesis
  • Transcription Factors / analysis
  • Transcription Factors / metabolism*
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • 15-deoxy-delta(12,14)-prostaglandin J2
  • Adenylyl Cyclase Inhibitors
  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • Lipopolysaccharides
  • NF-kappa B
  • Receptors, Cytoplasmic and Nuclear
  • STAT1 Transcription Factor
  • Trans-Activators
  • Transcription Factors
  • Tumor Necrosis Factor-alpha
  • 9-(tetrahydro-2-furyl)-adenine
  • Nitric Oxide
  • Interferon-gamma
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
  • Adenine
  • Dinoprostone
  • Prostaglandin D2